ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
ASFOTASE ALFA
Active substance (INN) · ATC A16AB13 · 2 products authorised in Romania
1
Protocols it appears in
As a medicine of the protocol (in the title) or only mentioned in the text
| Code | Protocol | Status | Role | Sublist | GP |
|---|---|---|---|---|---|
| A16AB13 | ASFOTAZA ALFA | In force | mentioned in the text | C1-G22 | NO |
2
Authorised brand products (ANMDM)
The Romanian register of medicines for human use, updated daily
| Brand name | Form | Strength | Holder | ATC | Rx |
|---|---|---|---|---|---|
| STRENSIQ 100 mg/ml | SOL. INJ. | 100mg/ml | ALEXION EUROPE SAS - FRANTA | A16AB13 | PR |
| STRENSIQ 40 mg/ml | SOL. INJ. | 40mg/ml | ALEXION EUROPE SAS - FRANTA | A16AB13 | PR |